Loading...

NMTC NEUROONE MEDICAL TECHNOLOGIES CORP Management Changes 8-K Filing

NRN

NMTC

NEUROONE MEDICAL TECHNOLOGIES CORP

(NMTC)

2024 8-K

Show Summary

Summary

Financial Statements

Non-Compliance With Listing...

Equity Incentive Plan

Annual Meeting Results

Financial Results

Nasdaq Compliance

Shareholder Update

Nasdaq Compliance

Preliminary Results

Financial Results

Loan Termination

Distribution Agreement

Executive Changes

Financial Results

Bylaws Amendments

Financial Results Announcement

Annual Meeting Results

Financial Results Announcement

Financial Results Announcement

FDA Clearance for OneRFTM A...

Patent Issuance

Appointment of COO

FDA Questions Response

Financial Results Announcement

Underwriting Agreement

Financial Results Announcement

Annual Meeting Results

Regulation FD Disclosure

Financial Results Announcement

Appointment of Transfer Agent

External Links:

NeuroOne Medical Technologies Corp amended employment agreements for its executives, enhancing severance benefits in case of a change in control, with CEO David Rosa set to receive 2.0 times his salary and bonus, while other executives will receive 1.25 times their salary and bonus, along with extended health insurance coverage.

AI Assistant

NEUROONE MEDICAL TECHNOLOGIES CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.